XML 48 R36.htm IDEA: XBRL DOCUMENT v3.25.1
EQUITY (Tables)
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Warrants Outstanding and Exercisable The following table summarizes the status of warrants and related transactions:
Non-Derivative (Equity) Warrants
Derivative Liabilities Warrants
Total Number of WarrantsWeighted - Average Exercise Price
Balance as of January 1, 2025
50,518,53621,400,00071,918,536$1.03 
Granted (1)
8,010,626 — 8,010,626 $0.48 
Balance as of March 31, 2025
58,529,16221,400,00079,929,162$0.98 
Exercisable as of March 31, 2025
56,959,16221,400,00078,359,162$0.98 
(1)In February 2025, the Company issued 8,010,626 warrants in connection with Second Lien Notes issuances. Refer to Note 8 - Debt for more information.
Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions The following assumptions were used for the calculation at date of issuance:
Weighted average stock price$0.33
Weighted average expected stock price volatility91.8%
Expected annual dividend yield0%
Weighted average expected life of warrants
5.0 years
Weighted average risk-free annual interest rate4.1%
Weighted average grant date fair value$0.22
Schedule of Stock Options Outstanding
The following table summarizes the status of stock options and related transactions:
Number of Stock OptionsWeighted-Average Per Share Exercise Price
Issued and Outstanding as of January 1, 202526,769,419 $0.79 
Granted670,000 $0.30 
Cancelled/forfeited/expired(2,728,667)$0.76 
Issued and Outstanding as of March 31, 202524,710,752 $0.78 
Exercisable as of March 31, 202514,060,630 $0.96 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following assumptions were used for the calculation at date of grant:
Three Months Ended March 31,
20252024
Weighted average stock price$0.29$0.70
Weighted average expected stock price volatility92.0%77.1%
Expected annual dividend yield0%0%
Weighted average expected life5.0 years5.1 years
Weighted average risk-free annual interest rate4.0%4.3%
Weighted average grant date fair value$0.21$0.46
Schedule of Components of Share-based Compensation Expense
The components of share-based compensation expense are as follows:
Three Months Ended March 31,
20252024
Stock options expense (forfeiture)
$(381)$1,355 
Restricted stock— 1 
Warrants74 168 
Total share-based compensation expense (forfeiture)
$(307)$1,524